Penyakit Jantung Tiroid, Penyakit Jantung Rematik, Dan Penyakit Jantung Anemi (PD)
Penyakit Jantung Tiroid, Penyakit Jantung Rematik, Dan Penyakit Jantung Anemi (PD)
Pendahuluan
Demam Rematik
proses radang akut tenggorokan yang
mayoritas
Epidemiologi
1994:
2005:
Indonesia:
0,3-0,8 diantara 1000 anak
sekolah Indonesia menderita demam
rematik 2
DEMAM REUMATIK :
- >> 5 15 THN.
- DAN JARANG < 5 THN.
MANIFESTASI KLINIS :
- ARTRITIS (70%)
- KARDITIS (50%)
- KHOREA (15%)
- NODULUS SUBKUTAN & ERITEM
MARGINATUM (5%)
3
DIAGNOSIS PJR
KRITERIA JONES
(2 MAYOR ATAU 1 MAYOR + 2 MINOR)
Diagosis karditis :
. Perubahan sifat bising jantung organik
. Ukuran jantung bertambah
. Bising gesek perikardial/efusi perikardial
. Tanda gagal jantung kongestif
Nodul subkutan : nodul kecil, seukuran kacang,
lokasi pada tendo ekstensor tangan, kaki, siku, tepi
patela, kulit kepala.
Khorea : gangguan sistim syaraf pusat yang ditandai
gerakan tiba-tiba, tanpa tujuan, tidak teratur,
kelemahan otot, emosi tak stabil.
Eritem marginatum : ruam merah bersifat
sementara, berpindah-pindah, tidak gatal, tidak
indurasi, memucat pada tekanan.
Test antibodi streptokokus : standarisasi paling
luas digunakan Pasien DR titer > 200 unit/ ml.
EKOKARDIOGRAFI DOPPLER :
- RUANGAN JANTUNG
- FUNGSI VENTRIKEL
- DERAJAT REGURGITASI KATUP
6
PENATALAKSANAAN :
1. ISTIRAHAT
2. ERADIKASI KUMAN
3. ANTI RADANG
4. SUPORTIF
5. PROFILAKSIS SEKUNDER
6. PENYULUHAN
7. OPERASI
7
TERAPI
1 Salisilat
2. Penisilin (Tx AHA):
Anak anak: Benzathin penicilline 600.000-900.000 U
Dewasa: Benzathin penicilline 1,2 juta U
Ataau : oral Penicilline 4 x 250 mg/ hari (10 hari)
atau kombinasi IM daan oral (10 hari)
Bila alergi peniciline eritromisin 4 x 250 mg (10 hari)
3. Kortikosteroid
4. Bed rest
5. TKTP
6. Penenang untuk chorea
PROFILAKSIS TERHADAP
KEKAMBUHAN
Jauhi penderita URI
2. Penisilin
Pada non RHD: min 3-5 tahun
Pada RHD, resiko tinggi: selama mungkin
3. Sulfonamides
4. Pengobatan sedini mungkin URI
1.
Prevensi Primer
Profilaksis Sekunder
Durasi Profilaksis
Hyperthyroidism
Hyperthyroidism is a relatively common disease that occurs more often in
women than men, with a peak incidence in the third and fourth decades.
Signs and symptoms : fatigue, hyperactivity, insomnia, heat intolerance,
palpitations, dyspnea, increased appetite with weight loss, nocturia,
diarrhea, oligomenorrhea, muscle weakness, tremor, emotional lability,
increased heart rate, systolic hypertension, hyperthermia, warm moist skin.
Hyperthyroidism is the clinical state resulting from excess production of T4,
T3 or both.
The most common cause is a diffuse toxic goiter
The second most common form of hyperthyroidism is nodular toxic goiter
Serum T4 levels are increased and serum TSH is suppressed.
CARDIOVASCULAR MANIFESTATIONS
CARDIOVASCULAR MANIFESTATIONS
CARDIOVASCULAR MANIFESTATIONS
CARDIOVASCULAR MANIFESTATIONS
CARDIOVASCULAR MANIFESTATIONS
CARDIOVASCULAR MANIFESTATIONS
Intraatrial conduction disturbances, manifested
by prolongation or notching of the P wave and
prolongation of the PR interval in patients with
hyperthyroidism.
Second - or third-degree heart block may result.
The cause of the AV conduction disturbance is
not clear.
CARDIOVASCULAR MANIFESTATIONS
CARDIOVASCULAR MANIFESTATIONS
Angina and CHF occur in patients with hyperthyroidism.
Five lines of evidence have suggested:
(1) CHF has been produced in animals by administering T4.
(2) CHF in children with thyrotoxicosis and no underlying cardiac
disease.
(3) Angina reported in a hyperthyroid Px with normal coronary arteries,
presumably secondary to thyroid-induced coronary artery spasm.
(4) The abnormal left ventricular function observed in hyperthyroid Px
is not reversed by beta blockade but is reversed by treating the
hyperthyroidism.
(5) The cardiomyopathy in patients with thyrotoxicosis may be
irreversible.
DIAGNOSIS OF HYPERTHYROIDISM
Hyperthyroidism in most patients is clinically
manifested as described above.
The diagnosis is confirmed with a low TSH level,
which reflects an elevated level of TH in the blood.
In elderly patients with apathetic hyperthyroidism,
cardiovascular manifestations predominate,
specifically, AF and/or CHF.
TREATMENT OF CARDIOVASCULAR
MANIFESTATIONS OF
HYPERTHYROIDISM
Beta blockers can be administered, with caution in